Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway
Katie Twigger(Institute of Cancer Research), Kevin J. Harrington(Royal Marsden NHS Foundation Trust)
Cited by 62
Related Papers
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
|Oncolytic Virotherapy|2016|75
Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma
|British Journal of Cancer|2016|18
Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer
|Cancer Research Communications|2025|1